We aim to make the process as straightforward as possible, ensuring you receive the care and support you need without delay
FDA Category 2 status AOD-9604 was previously nominated for inclusion under FDA's Category 2 list (substances proposed for compounding under research/evaluation)
Visit Us: Drop by the pharmacy to discuss your needs and book your injection in person
What I mean is the difference between intramuscular B12 injections and Subcutaneous B12 injections
I'm not medically trained
FDA Advisory Committee Votes to Ease Peptide Restrictions: What the July 2026 Vote on BPC-157, KPV, TB-500, and MOTS-c Actually Means An FDA advisory committee voted on July 23, 2026 to recommend easing restrictions on four peptides BPC-157, KPV, TB-500, and MOTS-c